Levetiracetam XR

DRUG2 trials

Sponsors

Neuraxpharm Pharmaceuticals S.L., National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Conditions

AlcoholismRefractory Partial Onset Epilepsy

Phase 2

Levetiracetam XR in Very Heavy Drinkers

CompletedNCT00970814

National Institute on Alcohol Abuse and Alcoholism (NIAAA)Alcoholism

Start: 2009-10-31End: 2010-10-31Updated: 2014-08-28

Phase 3

A Double-Blind, Randomized, Placebo and Active Controlled Study to Evaluate the Efficacy and Safety of Once Daily, Extended Release Levetiracetam as Add-on Therapy in Patients with Refractory Partial Onset Epilepsy.

RecruitingCTIS2024-514499-42-00

Neuraxpharm Pharmaceuticals S.L.Refractory Partial Onset Epilepsy

Start: 2025-03-12Target: 134Updated: 2025-10-08